Bio-Rad Laboratories
BIO
#2323
Rank
$6.65 B
Marketcap
$247.05
Share price
-0.65%
Change (1 day)
-15.36%
Change (1 year)
Bio-Rad Laboratories, Inc. is an American manufacturer of products for the life science research and clinical diagnostics markets.

P/E ratio for Bio-Rad Laboratories (BIO)

P/E ratio as of May 2025 (TTM): -3.24

According to Bio-Rad Laboratories's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.2434. At the end of 2024 the company had a P/E ratio of -5.05.

P/E ratio history for Bio-Rad Laboratories from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-5.05-66.41%
2023-15.0334.11%
2022-3.47-165.43%
20215.3016.25%
20204.56-27.43%
20196.28-67.07%
201819.1-69.17%
201761.8-67.44%
2016190429.94%
201535.8-8.46%
201439.1-14.5%
201345.8160.61%
201217.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
15.0-561.45%๐Ÿ‡บ๐Ÿ‡ธ USA
24.2-846.44%๐Ÿ‡บ๐Ÿ‡ธ USA
33.7-1,137.53%๐Ÿ‡บ๐Ÿ‡ธ USA
26.0-900.64%๐Ÿ‡บ๐Ÿ‡ธ USA
16.9-622.47%๐Ÿ‡บ๐Ÿ‡ธ USA
38.1-1,274.88%๐Ÿ‡บ๐Ÿ‡ธ USA
36.3-1,219.37%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.